Outpatient Facility Coding Alert - 2005 Issue 24
CHEMOTHERAPY PAYMENTS: Drug Payments For These Commonly Prescribed Drugs Drop Up To 38 Percent In July
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s July 2005 updates to Medicare drug payment amounts for commonly used chemotherapy drugs and the broader context of ASP-based pricing changes. It is aimed at oncology practices, reimbursement staff, and coding/billing professionals who need to understand how the updated payment environment may affect physician-administered drug reimbursement. The discussion focuses on general payment trends, CMS’s rationale, and practice-level implications without providing detailed coding instructions.
Why This Topic Matters
It helps readers understand a major payment update affecting oncology drug reimbursement and the potential operational impact on practices that administer these therapies.
What You Will Learn
- How CMS updated Medicare drug payment rates for commonly used chemotherapy drugs
- The overall direction of drug payment changes in July 2005
- Why these reimbursement changes matter for oncology practices
- How CMS framed the payment reform changes in relation to drug access and utilization
Who Should Read This
- Oncology practices
- Medical billing staff
- Coding professionals
- Reimbursement specialists
- Physician office administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com